SCHEMBL7572806

SCHEMBL7572806

O=S(=O)(Nc1ccc(F)cc1)c1cccc(C(F)(F)F)c1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 1/20 0.69
PGR P06401 1/20 0.69
AR P10275 1/20 0.69
ESR2 Q92731 1/20 0.69
HSD17B2 P37059 1/20 0.64
TSHR P16473 1/20 0.63
HDAC1 Q13547 1/20 0.62
HDAC8 Q9BY41 1/20 0.62
CA1 P00915 1/20 0.60
CA2 P00918 1/20 0.60
MMP1 P03956 1/20 0.60
MMP2 P08253 1/20 0.60
MMP9 P14780 1/20 0.60
MMP8 P22894 1/20 0.60
MMP13 P45452 1/20 0.60
KMT2A Q03164 4/20 0.58
MAPT P10636 3/20 0.58
MEN1 O00255 3/20 0.58
LMNA P02545 3/20 0.58
HSPD1 P10809 2/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3762909 0.88 PGR (0.77) NR3C1PGRARESR2HSD17B2
SCHEMBL7572556 0.87 PGR (0.67) NR3C1PGRARESR2HSD17B2
SCHEMBL97543 0.87 NR3C1 (0.67) NR3C1PGRARESR2HSD17B2
SCHEMBL5037026 0.84 NR3C1 (0.64) NR3C1PGRARESR2HSD17B2
SCHEMBL7573925 0.81 HSD17B2 (0.79) NR3C1PGRARESR2HSD17B2
SCHEMBL7571567 0.81 HSD17B2 (0.63) NR3C1PGRARESR2HSD17B2
SCHEMBL9517099 0.81 TSHR (0.69) NR3C1PGRARESR2HSD17B2
SCHEMBL7577535 0.81 CA1 (0.65) ARHDAC1HDAC8CA1CA2
SCHEMBL7833934 0.80 PGR (0.63) NR3C1PGRARESR2HSD17B2
SCHEMBL7594309 0.80 KMT2A (0.63) NR3C1PGRARESR2HSD17B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1239852-A2 BISSULFONAMIDE DERIVATIVES AS ENZYME INHIBITORS Arrow Therapeutics Limited (GB) 2002-09-18 EP disclosed
WO-2001028537-A2 BISSULFONAMIDE DERIVATIVES AS ENZYME INHIBITORS ARROW THERAPEUTICS LIMITED (GB) 2001-04-26 WO disclosed